Who owns ACTUATE THERAPEUTICS INC?
- Ticker: ACTU
- CUSIP Number: 005083100
Tip: Access positions for across all investors
Analyze quarterly positions in Actuate Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Actuate Therapeutics stock
Who bought or sold ACTUATE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BIOS Capital Management | 10M | $62M | 0% | Dec 2025 |
|
| Voss Capital | 1.3M | $8.0M | 45% | Dec 2025 |
|
| Vanguard Group | 529k | $3.2M | 67% | Dec 2025 |
|
| BlackRock | 432k | $2.6M | 53% | Dec 2025 |
|
| Geode Capital Management | 208k | $1.3M | 43% | Dec 2025 |
|
| Northern Trust | 101k | $621k | 19% | Dec 2025 |
|
| Texas Capital Bank Wealth Management Services | 95k | $579k | 100% | Dec 2025 |
|
| State Street Corporation | 56k | $345k | 13% | Dec 2025 |
|
| Charles Schwab Investment Management | 24k | $146k | 61% | Dec 2025 |
|
| Rock Creek Group | 22k | $133k | 100% | Dec 2025 |
|
| Wells Fargo & Company | 20k | $123k | 49% | Dec 2025 |
|
| SFMG Wealth Advisors | 20k | $122k | 18% | Dec 2025 |
|
| Gleason Group | 19k | $117k | 0% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 19k | $113k | -4% | Dec 2025 |
|
| Jane Street | 17k | $102k | 100% | Dec 2025 |
|
| Barclays | 15k | $92k | 69% | Dec 2025 |
|
| LPL Financial | 13k | $79k | -20% | Dec 2025 |
|
| Royal Bank of Canada | 13k | $0 | 876% | Sep 2025 |
|
| Bank of New York Mellon | 13k | $77k | 100% | Dec 2025 |
|
| Susquehanna International | 10k | $63k | 100% | Dec 2025 |
|
| Rhumbline Advisers | 9.5k | $58k | 9% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 9.3k | $57k | 640% | Dec 2025 |
|
| ABS Direct Equity Fund | 6.6k | $40k | 100% | Dec 2025 |
|
| Global Retirement Partners | 6.3k | $38k | 0% | Dec 2025 |
|
| New York State Common Retirement Fund | 6.2k | $38k | 0% | Dec 2025 |
|
| UBS Group | 5.1k | $31k | -43% | Dec 2025 |
|
| Mirae Asset Global Etfs Holdings | 4.4k | $27k | 65% | Dec 2025 |
|
| Jpmorgan Chase & Co | 2.5k | $17k | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 2.4k | $15k | 53% | Dec 2025 |
|
| Tower Research Capital | 1.6k | $10k | 0% | Dec 2025 |
|
| Legal & General Group | 1.3k | $7.8k | 81% | Dec 2025 |
|
| Advisor Group Holdings | 1.0k | $6.1k | 0% | Dec 2025 |
|
| Summit Investment Advisors | 601.00 | $3.7k | 0% | Dec 2025 |
|
| California State Teachers Retirement System | 585.00 | $3.6k | 59% | Dec 2025 |
|
| FMR | 573.00 | $3.8k | 84% | Sep 2025 |
|
| Russell Investments | 487.00 | $3.0k | 0% | Dec 2025 |
|
| Amalgamated Bank | 298.00 | $2.0k | 48% | Dec 2025 |
|
| CWM | 44.00 | $0 | -14% | Dec 2025 |
|
| Sterling Capital Management | 40.00 | $245.000000 | 167% | Dec 2025 |
|
| EverSource Wealth Advisors | 2.00 | $12.000000 | -97% | Dec 2025 |
|
| True Wealth Design | 1.00 | $7.000000 | 100% | Dec 2025 |
|
Who sold out of Actuate Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Freestone Capital Holdings | Sep 2025 | 10k | $67k |
| Northwestern University | Sep 2025 | 6.5k | $43k |
| Sontag Advisory | Sep 2025 | 5.0k | $34k |
| Prosight Management | Sep 2025 | 885.00 | $5.9k |
| Pnc Financial Services | Sep 2025 | 384.00 | $2.6k |
| SRS Capital Advisors | Sep 2025 | 60.00 | $400.998000 |